On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of plasma was predicted to double to 6 million liters annually.

Grifols’ products are used to treat rare, chronic diseases such as a neurological disorder, immune deficiencies, hemophilia and genetic emphysema.